Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
I understand you to recommend that if in the evaluation of a child
for other allergies, peanut SPT sensitivity is noted in the absence of a
history, that nevertheless that child should avoid peanut products.
Can you explain how you come to that recommendation?
Peanut avoidance on basis of skin tests only
Dear Dr Sampson,
I understand you to recommend that if in the evaluation of a child
for other allergies, peanut SPT sensitivity is noted in the absence of a
history, that nevertheless that child should avoid peanut products.
Can you explain how you come to that recommendation?
Cheers
John Ziegler
Sydney
Competing interests: No competing interests